Axon Enterprise, Inc $AXON Stock Holdings Increased by Duncker Streett & Co. Inc.

Key Points

• Duncker Streett & Co. Inc. increased its holdings in Axon Enterprise, Inc by 3.2%, owning 14,501 shares valued at approximately $12 million, making it Axon's 11th largest position.
• Insider activity saw President Joshua Isner and another insider sell a combined 23,810 shares for over $17 million, reflecting a decrease in their ownership stakes.
• Analysts are optimistic about Axon Enterprise, with a majority rating it as a “buy” and setting a consensus target price of approximately $841.64 for the stock.

Duncker Streett & Co. Inc. increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,501 shares of the biotechnology company's stock after purchasing an additional 448 shares during the quarter. Axon Enterprise accounts for 2.2% of Duncker Streett & Co. Inc.'s holdings, making the stock its 11th biggest position. Duncker Streett & Co. Inc.'s holdings in Axon Enterprise were worth $12,006,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in AXON. TCTC Holdings LLC raised its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after acquiring an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC raised its holdings in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after acquiring an additional 33 shares during the period. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the first quarter valued at approximately $31,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise during the first quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise during the first quarter valued at approximately $33,000. 79.08% of the stock is currently owned by institutional investors.

Insider Activity

In related news, President Joshua Isner sold 15,919 shares of the company's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. This represents a 6.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the company's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 5.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on AXON shares. Bank of America boosted their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Piper Sandler initiated coverage on shares of Axon Enterprise in a research report on Tuesday, September 23rd. They set an "overweight" rating and a $893.00 price objective on the stock. Needham & Company LLC reaffirmed a "buy" rating and set a $870.00 price objective on shares of Axon Enterprise in a research report on Wednesday, September 24th. Craig Hallum raised shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price objective on the stock in a research report on Tuesday, August 5th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Axon Enterprise in a research report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $841.64.

Axon Enterprise Price Performance

NASDAQ AXON opened at $704.67 on Wednesday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company has a fifty day simple moving average of $751.62 and a 200 day simple moving average of $715.98. The company has a market cap of $55.32 billion, a P/E ratio of 173.99, a P/E/G ratio of 27.57 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise's quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.